Publication | Open Access

Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management

Heart FailureOncologyCardiovascular DiseaseMedicineCardiovascular PharmacologyCardiologyPharmacotherapyProactive ManagementCardiovascular ToxicityPharmacologyAtherosclerosisReal-life Study